Apolipoprotein A-I (APOA1)(86-101) – Ion Channels and Transporters
Apolipoprotein A-I enables the efflux of fat molecules from within cells as high-density lipoprotein (HDL) particles for transport back into LDL particles or to the liver for excretion. HDLs are one of five major groups of lipoproteins. Increasing concentrations of HDL particles are strongly associated with decreasing accumulation of atherosclerosis within the walls of arteries. Apolipoprotein A-I is often used as a biomarker for prediction of cardiovascular diseases, such that low levels of APOA1 are associated with an increased risk of adverse events in patients with coronary artery disease. In such cases, APOA1 can be used as a biomarker to predict cardiovascular disease progression.
Technical specification
| Sequence : | H-EQLGPVTQEFWDNLEK-NH2 | |
| MW : | 1.930.9 g/mol | |
| Purity : | > 95% | |
| Counter-Ion : | TFA Salts | |
| Delivery format : | Lyophilized |
Price
| Product | Size | Price € | Price $ |
| CRB1000736-0.5 mg | 0.5 mg | 141€ | 170$ |
| CRB1000736-1 mg | 1 mg | 193€ | 232$ |